Chapter 4
It sometimes happens: Colorectal Cancer (or Bowel Cancer)
Dive deeper Into The topic
So, what can go wrong
inside your colon?
Those polyps sometimes become cancerous…
How frequent is colorectal cancer?

3rd most common cancer worldwide: more than 1.9 million new cases in 2022

2nd most deadliest cancer worldwide: more than 900 000 deaths in 2022

Highest incidence rates are in Europe, Australia / New Zealand and North America
Incidence rates are steadily increasing in countries that are undergoing economic transition, which likely reflects changes in lifestyle factors.
In high-income countries, an overall decline in the incidence of colorectal cancer has been noted, which has been attributed to population-level changes toward healthier lifestyle choices and the uptake of screening. However, a worrying rise has been observed in adults younger than 50 years old at diagnosis.

Further information
WHAT IS EARLY-ONSET COLORECTAL CANCER?
Early-onset colorectal cancer (EO-CRC) is colorectal cancer diagnosed before the age of 50. It may also be called early age onset colorectal cancer and young-onset colorectal cancer.

Since the 90s, the number of EO-CRC cases has been rising by about 1.5% each year, and sadly, so have the number of deaths related to it.

By 2030, it's estimated that colorectal cancer could be the leading cause of cancer deaths in people aged 20-49.

EO-CRC tends to be more aggressive and the outlook for young patients can be worse than for older ones.

Younger people with EO-CRC are often not diagnosed by organized screening, leading to delayed diagnoses.
Learn the symptoms of colorectal cancer and talk to your doctor if something doesn't feel right.

Further information
Many people with colorectal cancer don’t have any symptoms until the disease is advanced.
Symptoms and signs of colorectal cancer may include, but aren’t limited to:

An unexplained change in bowel habits that lasts for more than a few days

Stools that are narrower than usual

Blood in stools

Abdominal pain and/or discomfort (gas pains, bloating, fullness, cramps)

Unexplained weight loss

Extreme tiredness for no obvious reason

Lower back pain
People with colorectal cancer may experience one, some, all or none of these symptoms.
If you have these symptoms, it does not necessarily mean that you have colorectal cancer. They are the same as those of extremely common conditions, such as hemorrhoids and irritable bowel syndrome.
But do talk to your doctor!
In most cases, colorectal cancer is « sporadic », meaning that the cause is unknown.
5–10% cases are related to inherited genes that increase the risk for the disease.
Progress from benign adenomas to cancer (adenocarcinomas) is slow. It can take more than 10 years, sometimes even 20 years, offering a large window for early detection and optimised management. This is why regular screening over a long period is important.
From the mucosa, the cancer can spread through tissue, the lymph system and blood vessels. The stage used to define it describes the extent of its spread within the body:
The cancer is only in the mucosa.
It has grown into the submucosa or muscle.
It has grown through the muscle wall or through the outer layer of the bowel and may be growing into tissues nearby.
The cancer has spread to lymph nodes nearby.
The cancer may have spread to nearby lymph nodes. It has spread to other parts of the body such as the peritoneum, liver or lungs. Stage IV cancer is also called metastatic colorectal cancer.
Staging of colorectal cancer helps determine how advanced the disease is and how best to treat it.

Further information
How is colorectal cancer treated?
Treatment depends on the stage and type of the cancer, individual characteristics and the benefits/risks balance for the patient.
Treatments act on the cancer either locally (surgery, radiotherapy) or systemically, which means all over the body (chemotherapy, targeted therapy, immunotherapy) :

Surgery is the most common treatment for colorectal cancer. In early stages of the disease, it may be sufficient to remove the tumour. When it is possible, it may also be performed to remove metastatic lesions in patients with advanced disease.

Radiotherapy uses high-energy rays or particles to destroy cancer cells.

Chemotherapy uses drugs. It is given through the mouth (as a tablet) or the vein (as an injection, drip or infusion). It aims to kill or limit the growth of tumour cells. A patient may receive one drug at a time or a combination of different drugs.

Targeted therapy uses drugs that are designed to interfere with the growth of cancer cells. The aim is to block specifically the growth and spread of cancer cells and limit damage to healthy cells.

Immunotherapy aims to boost the body’s natural defenses (immune system) to fight the cancer.

Further information
You may have heard about biomarker testing. How does this help?
We are all different, tumours are too… That’s why biomarker testing is becoming increasingly important to guide treatment strategies especially in metastatic colorectal cancer.
But what are we talking about?
A biomarker is a biological molecule found in blood, other body fluids or tissues, which gives an indication of a normal or abnormal process, or of a condition or disease. It can be a change in DNA, RNA, or protein.
Cancer cells may have changes in genes (mutations) that can affect how the cancer grows. and define response (or lack of response) to therapy. Knowing them in a patient is like knowing the fingerprints of their hand. It is a characterisation of their tumour that can provide doctors with a great deal of information and help them find the most suitable treatment.
In metastatic colorectal cancer, the most common alterations are found in genes called RAS, BRAF and mismatch repair (MMR) genes.
Contact your healthcare professional or a patient association!
Healthcare professionals and patient associations are key contacts to get specific and accurate answers to your questions. Many patient associations provide information about prevention and screening, as well as advice and support to patients and families.
Don’t hesitate to contact them!
In Europe,
Digestive Cancers Europe (DiCE) is the umbrella organisation of a large group of national associations representing patients with colorectal cancer.
